Maximus (MMS)
(Delayed Data from NYSE)
$85.18 USD
+1.23 (1.47%)
Updated Oct 17, 2025 04:00 PM ET
After-Market: $85.16 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MMS 85.18 +1.23(1.47%)
Will MMS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MMS
New Strong Buy Stocks for Oct. 14: HBM, GCT, and More
Is Montrose Environmental Group (MEG) Stock Outpacing Its Business Services Peers This Year?
MMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights include Maximus, Pediatrix Medical, Sally Beauty and State Street
4 Stocks Trading Near 52-Week High With Room to Rise Further
Here's Why You Should Retain Verisk Stock in Your Portfolio Now
Other News for MMS
Lower Bollinger Band Walk appears for MMS after 0.08% move
MMS forms MACD Bearish Centerline Cross on October 15
Doji - Bullish? appears for MMS after 0.56% move
Maximus (MMS) Secures $31M Contract for Massachusetts Health Enrollment Services
Maximus awarded $31M contract by Massachusetts Health Connector